| Ytd | 57.83% | |
| 1y | 54.02% |
| Open | 13.16 | Prev Close | 13.49 | Low | 13.16 | High | 14.29 | Mkt Cap | 15.11M |
| Vol | 865.00 | Avg Vol | 40.49K | EPS | -1.96 | P/E | -6.88 | Forward P/E | N/A |
| Beta | -1.59 | Short Ratio | 0.08 | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 13.66 | 200-d Avg | 11.55 | 1yr Est | 0.00 |
Gainers NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session.
Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement
Polyrizon Ltd. (NASDAQ:PLRZ) (the "Company" or "Polyrizon"), a development-stage bio